2008
DOI: 10.1007/s00776-007-1184-4
|View full text |Cite
|
Sign up to set email alerts
|

Langerhans cell sarcoma emanating from the upper arm skin: successful treatment by MAID regimen

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
17
0
2

Year Published

2009
2009
2016
2016

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(19 citation statements)
references
References 15 publications
0
17
0
2
Order By: Relevance
“…Classical hematological schemes, such as CHOP and ESHAP, have been administered, 7 and other drug combinations with Adriamycin plus Ifosfamide, such as MAID (mesna, doxorubicin, ifosfamide, dacarbazine) have also been tested. 9,11,12 Nevertheless, the best option for systemic treatment of LCS has not yet been established.…”
Section: Discussionmentioning
confidence: 98%
“…Classical hematological schemes, such as CHOP and ESHAP, have been administered, 7 and other drug combinations with Adriamycin plus Ifosfamide, such as MAID (mesna, doxorubicin, ifosfamide, dacarbazine) have also been tested. 9,11,12 Nevertheless, the best option for systemic treatment of LCS has not yet been established.…”
Section: Discussionmentioning
confidence: 98%
“…Local resection is commonly applied to isolated LCS lesions (Table I). Chemotherapies, such as a modified ESHAP (etoposide, carboplatin, cytarabine, and methylprednisolone) (20) and MAID (mesna, doxorubicin, ifosfamide, dacarbazine) (21) regimens, have been demonstrated to be effective in a proportion of patients. Radiotherapy has also been reported to be effective in certain cases.…”
Section: Discussionmentioning
confidence: 99%
“…Yoshimi et al [6] proposed a modified ESHAP program as salvage therapy if CHOP regimen fails. Uchida et al [14] reported a case in which MAID regimen successfully treated LCS emanating from the upper arm cutaneous tissue. Moreover, Ferringer et al [15] used doxorubicin and ifosfamide in an LCS patient to achieve complete remission in 3 months and no recurrence after 8 months of follow-up.…”
Section: Discussionmentioning
confidence: 99%